H eterotopic ossification is an abnormal, benign formation of new bone in either soft tissue or on the external surface of an affected bone. 1 The condition is characterized by rapidly progressive proliferation and maturation of mesenchymal stem cells, the progenitors of osteoblasts and certain other types of cells. 2 This proliferation occurs as a result of damage to muscles and other soft tissues, typically in skeletal muscle close to bone. 3 Heterotopic ossification sometimes is referred to as "myositis ossificans," which is the term used by the American College of Radiology in its appropriateness criteria for diagnosis of soft-tissue masses. 4 The term myositis ossificans is descriptive in that it refers to inflammation of skeletal muscle tissue due to the development of bony deposits within that muscle. 5 However, this term is somewhat of a misnomer because soft tissues other than muscle can be involved, including tendons, ligaments, fascia, and aponeuroses (fibrous membranes that bind muscles together as a means of connecting muscle to bone). 6 Furthermore, some authors consider heterotopic ossification and myositis ossificans to be distinct entities. 3, [7] [8] [9] Other terms used to describe this atypical formation of bone in soft tissue include paraosteoarthropathy, periarticular new bone formation, ectopic bone formation, neurogenic ossifying fibromyopathy, and heterotopic calcification. 10 
Types of Heterotopic Ossification
Several categories of heterotopic ossification exist based on the triggering event for its formation, including traumatic, neurogenic, genetic, and idiopathic types. 7 Traumatic heterotopic ossification is the most common, with as many as 75% of heterotopic ossification cases attributable to trauma. 3, 8 Traumatic heterotopic ossification also is known as posttraumatic myositis ossificans. It is considered a major complication of injury or surgery and can affect function and range of CE Directed Reading Heterotopic Ossification a wheelchair by the time they are 30 years of age and require substantial help to care for themselves. For these individuals, even minimal trauma such as normal bumping or vaccine injection can trigger new instances of bone formation, and surgical intervention for any reason is contraindicated. No effective treatment exists for fibrodysplasia ossificans progressive and, unfortunately, the median age of survival is less than 45 years. 17 In still other highly unusual instances, there is no identifiable cause of heterotopic ossification. Such cases are referred to as idiopathic. 20 For example, Shankar et al reported a rare case study of orbital involvement from idiopathic heterotopic ossification in a man aged 30 years in whom no evidence of tumor or other cause was found for ossification of the supraorbital ridge and portions of the zygomatic process. 21 Another case of idiopathic heterotopic ossification reported in the literature involved bone formation in the medial and lateral pterygoid muscles as well as the temporalis muscles, with resultant pain, swelling, and inability to open the mouth in a young woman with no history of trauma or infection.
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Epidemiology
Much has been written about the risk factors associated with the formation of heterotopic ossification. Sex is considered a risk factor, in that men are at a higher risk than women for developing this complication. 9 Obesity also could be linked to heterotopic ossification risk. A recent study investigated this idea based on research findings that adipose tissue releases chemicals that bring about chronic low-grade inflammation, a condition that might predispose a person to developing heterotopic ossification. The retrospective study involved 395 patients who received prophylactic radiation treatment following surgery for acetabular fractures and concluded that as body mass index increased, so did the risk of heterotopic ossification. 22 Medical conditions that place a patient in a higher risk category for heterotopic ossification include hypertrophic osteoarthritis, osteonecrosis, Paget disease, diffuse idiopathic skeletal hyperostosis, and ankylosing spondylitis.
9,11 Diffuse idiopathic skeletal hyperostosis, which is characterized by ossification of the anterior longitudinal ligament of the spine (see Figure 1) , is common among the elderly and predisposes a large motion negatively in the joint adjacent to the tissue where it has formed. 8, 11 Because dislocations attributed to trauma generally affect the proximal portion of the long bones in the extremities, these areas are most likely to be affected by traumatic heterotopic ossification.
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Burns affect thousands of people each year, and heterotopic ossification associated with severe burns is a wellknown complication. Some authors considered this complication traumatic heterotopic ossification.
10,13
Neurogenic heterotopic ossification, a subset of posttraumatic myositis ossificans, is associated with injuries to the central nervous system. 9 Patients with neurogenic heterotopic ossification are most likely to have an injury to the brain or spinal cord due to trauma. However, conditions such as encephalitis, meningitis, and brain tumors also have been implicated in the development of heterotopic ossification in some individuals. 10 When the spinal cord is damaged, joints affected by heterotopic ossification always are distal to the level of the injury.
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The joints most commonly affected in these patients are the hips; however, the shoulders and elbows also can be affected. The incidence varies according to the site of trauma, ranging from 11% to 73% for patients with a head injury and from 10% to 78% for individuals with a spinal cord injury. 15 Twenty percent of those patients experience some degree of functional loss. 16 The incidence can be even higher for severely injured patients who remain in a coma for 2 or more weeks.
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In addition, heterotopic ossification can develop as a consequence of mutations associated with the rare congenital disorder fibrodysplasia ossificans progressive, which is also known as myositis ossificans progressiva. 17, 18 For individuals with this genetic abnormality, the process of heterotopic ossification begins in early childhood. However, diagnosis often is delayed because symptoms such as soft-tissue inflammation and pain usually are associated with more common conditions such as mumps or sarcoma. 19 As early as young adulthood, fibrodysplasia ossificans progressive leads to ankylosis (rigidity and immobility) of the joints in both the axial and appendicular skeleton, which is one of the hallmarks of the disease. 10, 19 Most joints eventually are involved for individuals with fibrodysplasia ossificans progressive, including the temporomandibular jointthe site most often affected in the maxillofacial region. The condition is severely disabling; most patients use CE Directed Reading Adams developing heterotopic ossification. The most significant predisposing medical risk factor is a history of previous heterotopic ossification in the ipsilateral or contralateral hip following surgery.
9,11
As previously stated, severe trauma to a bone, especially at joint sites, is a common trigger for heterotopic ossification. The greater the trauma, the more likely it is that heterotopic ossification will develop. Massive trauma associated with wartime blast injuries places military personnel at a higher risk for developing heterotopic ossification than is found in the civilian population, with an incidence rate as high as 64% in one study at the National Naval Medical Center. 24, 25 The combination of head injury and severe trauma to an extremity increases the risk even further, and incidence of heterotopic ossification of the elbow might be as high as 89% in these circumstances. 24, 26 This is not a new problem for the military population. In 1918, heterotopic ossification was reported in the literature as a frequent complication for World War I soldiers who suffered combat injuries of the spinal cord.
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Clinical risk factors include a fracture with dislocation and multiple injuries at the time of trauma. Surgical risk factors vary with technical approaches used in total hip arthroplasty, open reduction-internal fixation, and trochanteric and femoral osteotomy procedures. 10 The most common site for heterotopic ossification is in the hip, although the elbow, knee, shoulder, and temporomandibular joints also can be affected.
Heterotopic ossification is the most common complication following total hip arthroplasty. The reported incidence rate in this population varies widely but might be as high as 53%
11 to 90%, 7 with up to 25% 27 of these patients eventually developing clinically significant symptoms if preventive treatment is not administered. Incidence rates of up of 50% have been reported in patients with acetabular fractures. 9 Although heterotopic ossification is not as common in the knee as in the hip, incidence has been reported to be as high as 42% following total knee arthroplasty.
27
The elbow is a common trauma site, and heterotopic ossification incidence rates of 50% or greater occur in cases of radial head fractures of the elbow.
12, 28 The elbow is also the most common site of heterotopic ossification involvement in patients with severe thermal or electrical burns, occurring in up to 3.3% of individuals with these types of burns.
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segment of the population to developing heterotopic ossification. 23 Rheumatoid arthritis also increases the chance of developing heterotopic ossification, although not as significantly as other factors.
9,11 Individuals with bilateral hip disease or full-thickness (third-degree) burns over 20% of the body also are at increased risk for 
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Additional signs and symptoms include erythema and swelling. If the patient has suffered a spinal cord injury, pressure sores over the site of heterotopic ossification might develop and can obscure the diagnosis of soft tissue infection or osteomyelitis in paralyzed individuals.
14 Although rare, peripheral nerve entrapment, which can cause severe pain and disability as a result of nerve damage, is another possible complication in advanced cases.
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Diagnosis
Imaging Examinations
Imaging is the basis for diagnosing symptomatic heterotopic ossification, by ruling out conditions such as infection or tumor, as well as monitoring asymptomatic individuals at high risk of developing heterotopic ossification. Although different imaging examinations can be used, the general consensus is that the stage of heterotopic formation is an important determinant of what can be seen with medical imaging modalities. Histologically, heterotopic ossification matures over
Etiology
The process of heterotopic ossification induction is only partially understood, and the exact pathophysiology of heterotopic ossification remains under investigation. Much of the research, especially early on, used experiments with rabbits, sheep, mice, and rats to advance the understanding of how heterotopic ossification develops. 7 Osteoblasts are necessary for bone formation, and heterotopic ossification is ultimately a result of an abnormality in the complex system of bone remodeling. The pathogenesis of heterotopic ossification is thought to be due to the inappropriate transformation of mesenchymal tissue into osteoblasts following trauma, including surgical manipulation. 10 This process results in new bone growth in tissues adjacent to the site of the injury where bone does not belong.
For osteogenesis to occur, there must be a predominance of osteoblastic stem cells as well as suitable environmental conditions. 29 For example, the formation of osteoblasts leading to bone deposition has been attributed to growth factors such as IGF-1, anatomic factors such as hypervascularity or immobility (especially in the spine), as well as genetic, metabolic, and toxic factors including free radical formation as a result of hypoxia due to trauma to the tissue. 23, 30 Inflammation and cell death associated with trauma induce calcium deposition as part of the process. 
Clinical Presentation
The vast majority of heterotopic ossification cases do not result in complications, and in many cases asymptomatic heterotopic ossification is noticed incidentally on a radiographic examination ordered for an unrelated reason (see Figure 2) . 10 Clinical signs and symptoms of heterotopic ossification depend on the amount of ossification and generally develop late in the course of the condition. 16 Early signs and symptoms (eg, fever, inflammation, pain, and decreased joint mobility) are often nonspecific. Differential diagnoses include cellulitis, thrombophlebitis, osteomyelitis, and tumors. 16, 19 When heterotopic ossification becomes noticeable, the earliest sign is restricted range of motion. The most common clinical symptom is pain. However, patients with heterotopic ossification who have lost sensory perception because of a spinal cord injury might not report any pain. 15 If the hip is affected, a limp is not unusual. 
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Adams based on patient symptoms. 8 CT can detect nuanced changes in cortical and medullary bone, which makes it ideal for detecting ossification in soft tissues. CT also can readily identify all 3 zones of active heterotopic ossification. 31 time, and tissue changes can be identified as peripheral, intermediate, or central on imaging studies. A rim of mature bone around the edge of a lesion is a characteristic finding of heterotopic ossification on radiographs, but some modalities can reveal this feature sooner. 31 It is not unusual for physicians to order a combination of imaging techniques.
Radiography
Conventional radiography is a valuable tool for heterotopic ossification diagnosis, staging, and treatment follow-up. For example, radiographs taken at intervals of several weeks to months after surgical repair and prophylactic radiation therapy, with or without drug therapy, following traumatic fractures to the elbow and hip can be used to check for heterotopic ossification, avascular necrosis, and loosening of prosthetic devices, as well as to evaluate healing of the fracture. 32, 33 Radiographs can demonstrate heterotopic ossification clearly and are relatively inexpensive and widely accessible (see Figure 3) . Radiographic evidence of heterotopic ossification can be seen 3 to 6 weeks after its initiation, with maximal extent by 6 to 12 weeks. 19 However, radiographs are not as sensitive as ultrasonography or radionuclide bone scans to the earliest development of heterotopic ossification and can even appear normal when heterotopic ossification is in the acute phase.
6
Computed Tomography
Despite the higher cost and increased radiation dose as compared with conventional radiography, computed tomography (CT) is the diagnostic modality of choice in many instances (see Figure 4 ). It often is ordered when standard radiographic images are suspicious, surgery is contemplated, or differential diagnosis is necessary 
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It is essential to understand and identify the evolution and stage of heterotopic ossification because recurrence is much more frequent following surgical removal of immature, new bone than when excision is reserved for bone that has reached the chronic phase. For this reason, 3-phase bone scans might be ordered serially at intervals of between 1 and 6 months following onset of acute clinical symptoms to document changes that will guide the timing of surgical resection. When bone scans are to be used for this purpose, consistent patient positioning is necessary to increase the validity of comparisons between scans.
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Magnetic Resonance Imaging
Magnetic resonance (MR) imaging is used in some cases of heterotopic ossification. For example, MR frequently is used in the diagnosis of osteomyelitis when skin ulceration accompanies heterotopic ossification in bed-ridden patients. However, Ledermann et al reported that MR signal intensity characteristics are similar for soft-tissue infection, abscesses, osteomyelitis, and heterotopic ossification, making the differential diagnosis very difficult in these cases.
14 Ledermann et al also suggested that MR is not sensitive or specific enough to identify early grade (immature) heterotopic ossification and
Nuclear Medicine Imaging
Nuclear medicine provides an additional diagnostic tool. Three-phase nuclear medicine bone scans can detect heterotopic ossification within 2 to 4 weeks after trauma. Bone scans can be used to confirm a diagnosis of heterotopic ossification or determine the need for treatment (see Figure 5) . 19 Neitzcham described the use of nuclear medicine imaging to diagnose and evaluate the evolution of heterotopic ossification of the hip associated with paraplegia secondary to a spinal cord injury. 34 In the Neitzcham study, patients underwent an anterior bone scan using technetium Tc 99m methylene diphosphonate along with an anterior radiograph of the pelvis. The radiographs did not demonstrate any obvious signs of ossification during the acute phase of the process.
The bone scan findings depended on the stage of the process at the time of imaging. In the subacute phase, for example, the bone scans showed an increase in activity. In the acute phase, bone scan findings were present prior to radiographic changes. During the chronic active maturing phase, activity decreased somewhat, and bone scans in the chronic mature phase eventually returned to normal. The time interval for the scans to move from one state to the next varied. 
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Adams as 3.5 times higher than normal. In most people, alkaline phosphatase levels return to pretrauma levels at 18 weeks. However, caution is advised in using alkaline phosphatase as a conclusive indicator of the maturity of heterotopic ossification because some patients with active disease, characterized by continued bone formation, never have abnormal levels and others with stable heterotopic ossification have values that never normalize. Despite its limitations, the alkaline phosphatase test frequently is ordered because of the ease of obtaining blood and the low cost of the test.
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Prostaglandins are chemical substances released in response to inflammation that regulate osteoblasts.
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Although not commonly measured, Prostaglandin E (PGE 2 ) is another potential marker of osteoblastic activity. Measuring the level of PGE 2 is more time consuming than measuring alkaline phosphatase levels because of the need to monitor the urinary excretion of PGE 2 over a 24-hour period. Patients with a spinal cord injury, already at increased risk of neurogenic heterotopic ossification, often have high levels of PGE 2 in their blood and this marker might be of particular value in that patient population.
28 If the level of PGE 2 increases suddenly, imaging studies might be indicated.
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Classification
Once a diagnosis of heterotopic ossification is established, the extent of the problem is generally described via the Harris Scale and the Brooker classification system, both of which were designed for use with the hip.
36,37 The Harris hip scale is a method for rating hip function and was formulated to be equally applicable to different hip problems and methods of treatment. It incorporates important variables such as pain, function, range of motion, and degree of deformity into a single reproducible and objective rating. 38 Pain and the degree of functional capacity are the most significant factors in the rating scale because they are the major indications for surgery in most patients with hip problems.
Brooker et al proposed a system to classify the degree and presence of ectopic bone formation following total hip replacement. 37 Using the Brooker system, each patient was graded both preoperatively and postoperatively using the Harris hip rating scale. In addition, preoperative radiographs of the hip were compared with images taken at least 6 months postoperatively to determine the emphasized the value of having a CT scan or radiograph available for comparison.
In patients without neurologic injuries, heterotopic ossification can mimic the appearance of soft-tissue sarcoma and benign lesions such as chondroma. Thus, MR imaging in combination with CT is recommended to diagnose and stage heterotopic ossification in the maxillofacial area. 20 Although heterotopic ossification is a distinct entity clinically, radiologically some confusion exists, and heterotopic ossification sometimes is mistaken as an osteosarcoma. Ehara et al found that careful analysis of the features of zone phenomena on MR imaging is important to differentiate between osteosarcoma and heterotopic ossification.
3 Zone phenomena refers to differences in maturity of ossification moving from the periphery to the center of the lesion. In these cases, it also is critical to evaluate the zonal architecture of the tissue pathologically.
20,31
Ultrasonography
Ultrasonography can detect calcification earlier than radiographs can and might be used to determine when heterotopic ossification lesions have reached maturity based on the presence of a calcified rim and the amount of reflection.
8 Ultrasonography is cost effective and can accurately identify changes predictive of heterotopic ossification only 1 week after surgery. 28 However, the use of ultrasonography to diagnose heterotopic ossification requires extensive radiologist experience because of the amount of "bone shadow" on ultrasound images. Ultrasonography has been used much more extensively in the United Kingdom than in the United States where it is infrequently used for this purpose (M Dixon, DO, personal communication, February 2014).
Laboratory Tests
Although imaging studies are the primary method of diagnosis, laboratory studies also are reported to be useful for screening of heterotopic ossification. For example, changing values of the enzymes alkaline phosphatase and acid phosphatase are associated with the transformation of mesenchymal cells immediately following trauma. 29 In particular, alkaline phosphatase, an enzyme associated with bone growth, has been found to be of some value.
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Alkaline phosphatase levels can rise as soon as 2 weeks after trauma occurs, and within 10 weeks can be as much CE Directed Reading Heterotopic Ossification most common; patients with neurogenic heterotopic ossification typically undergo physical therapy as part of their treatment.
The cost associated with treatment varies according to the method chosen, but primary prevention is less expensive than treating symptomatic heterotopic ossification. When considering costs, it has been suggested that an accurate comparison should include not only direct costs of treatment but also costs related to adverse effect management, treatment failure, and the opportunity cost of lost wages. In such a cost comparison of the most commonly used drug regimen and radiation therapy, Strauss et al concluded that nonsteroidal antiinflammatory drugs (NSAIDs) were almost as expensive as radiation therapy, even though the direct cost of treatment alone was more than 400 times higher for radiation.
40
This was due to the increased cost of surgical revision and treatment of gastrointestinal bleeding, which were much higher in the patient group that received indomethacin than the group that received radiation therapy.
Surgical Excision
Surgical excision is the primary option for patients who have clinically significant effects of heterotopic ossification, and it is the only viable treatment capable presence and extent of postoperative ectopic bone formation. Brooker concluded that class I, II, or III ectopic bone formation did not significantly change the result achieved with total hip arthroplasty as determined by degree of improvement on the Harris hip scale. Thus, although patients with femoral-head prostheses were more likely to have ectopic ossification after total hip replacement than they were before surgery, they did not necessarily have poor functional results.
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In general, heterotopic ossification scored as Brooker class I or II is asymptomatic and clinically insignificant. However, patients who develop more severe heterotopic ossification (class III or IV) are at increased risk for subsequent ectopic bone lesions of equal severity, especially after total hip arthroplasty. Thus, these patients are likely candidates for prophylactic treatment.
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Although the Brooker classification system is the most widely used, it might not be relevant in sites other than the hip or for neurogenic heterotopic ossification because it does not specify the muscle compartment involved in heterotopic ossification and therefore is of limited value for planning surgical excision and predicting prognosis. 39 For this reason, additional classification systems have been proposed for other anatomic sites. For example, in the elbow, functional status can be measured via the Mayo Elbow Performance Score, which rates pain, range of motion, joint stability, and ability to carry out daily activities such as dressing, hair combing, and other personal hygiene activities to determine an overall score. Heterotopic ossification that is apparent on radiologic imaging can be categorized using the traditional Brooker system or with classifications proposed by Hastings and Graham (see Table) or Ilhali et al.
26,32
Treatment
Several methods minimize or prevent the functional deficits and pain associated with heterotopic ossification. These include surgical excision, physical therapy, drug therapy, and radiation therapy. Each of these options has corresponding advantages and disadvantages, and controversy exists in the literature regarding the most appropriate treatment because none has proven effective in all patients. A combination of 2 or more treatment methods is used in many instances. For primary prevention of traumatic heterotopic ossification, drug therapy and radiation therapy are 16 Physical therapy should be started as soon as possible after an injury or surgery. 47 Although the value of physical therapy is not universally accepted in all patients who are at risk for heterotopic ossification, passive range of motion exercises as part of rehabilitation efforts can impede development of fibrous ankylosis. 41 It also has been suggested that motion itself might prevent bone from forming. For example, in Figure 1 , the area directly under the aorta is spared from ectopic bone formation most likely because the aorta constantly moves as a result of dynamic blood flow (M Dixon, DO, personal communication, February 2014). For patients with neurogenic heterotopic ossification requiring excision, range of motion of the affected joint should be monitored continually, especially in patients with brain injuries because they are more likely to have a recurrence of heterotopic ossification than those with spinal cord injuries.
39
Physical therapy also can be used postoperatively in the absence of neurologic injuries to prevent scar formation that might limit range of motion.
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Pharmacology
The efficacy of drug therapy for preventing heterotopic ossification is well established and this treatment method widely is used. 44, 48 Diphosphonates and NSAIDs such as ibuprofen, indomethacin, Voltaren Resinat, and acetylsalicylic acid (aspirin) have been studied. Diphosphonates no longer are recommended because they were found to prevent the onset of heterotopic ossification only while the patient was taking the medication and had no permanent protective effect. 40 NSAIDs are the currently preferred drugs for chemoprophylaxis, with indomethacin as the most commonly used for prevention of heterotopic ossification. The NSAIDs are thought to work by suppressing prostaglandin-induced inflammation associated with traumatic tissue damage.
12,40,49
Based on their ability to prevent or disrupt bone remodeling, there is a possibility that NSAIDs also prevent bone growth to noncemented prosthetic devices, which would necessitate surgical revision. 48 In addition to concerns about the risk of bone inhibition, orthopedists must consider the adverse effects of NSAIDs, which can include gastric ulcers, increased risk of bleeding, renal toxicity, and allergic reaction. Because of the potential for such adverse effects, patients with a history of liver or kidney failure, gastric ulcers or an aspirin of removing mature ectopic bone.
11 Timing of the surgery is important and excision should not be undertaken until the heterotopic ossification is fully mature. This typically takes several months to more than 1 year, depending on the underlying condition. Traumatic injury directly to a musculoskeletal site might demonstrate mature heterotopic ossification within 6 months, whereas heterotopic ossification associated with spinal cord injuries takes approximately twice as long to mature.
19 Surgery should be delayed even longer in patients with brain injury and is generally not done sooner than 18 months following the injury.
41
Relevant clinical manifestations most often include pain, swelling, and reduced range of motion. The ideal surgical candidate will not have any signs of acute heterotopic ossification, such as fever, erythema, swelling, or an increased alkaline phosphatase level. Although some loss of range of motion can be accepted, significant limitations (eg, less than 50° for the hip) are indicators for surgical excision. 19 In such cases, failure to excise the heterotopic ossification can result in progression to complete ankylosis of the affected joint. Ankylosis can be severely debilitating and prevent the patient from walking, dressing, or eating independently. For this reason, surgery is indicated in most cases, with the notable exception of heterotopic ossification due to fibrodysplasia ossificans progressive.
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This surgery can be technically difficult, as is often the case in the elbow where bone can encase the ulnar nerve completely. 42 Other challenges of surgery include difficulties encountered in revising or replacing original prosthetic components. 43 The risk of recurrence once excess bone has been removed is reportedly as high as 80% to 100%, and it is important to prevent new heterotopic ossification. 26 The goal of preventing recurrence following excision is known as secondary prophylaxis.
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Most studies have found that drug therapy and radiation therapy are equally effective. [44] [45] [46] Thus, the choice of which preventive modality to use following surgery depends on the risk of infection, issues with wound healing or other comorbid conditions, and the need to use warfarin to prevent deep venous thrombosis.
10,42
Physical Therapy
Physical therapy can preserve range of motion in a joint and is especially important in individuals with a CE Directed Reading Heterotopic Ossification pluripotential stem cells to osteoblasts, which are also undifferentiated, this radiobiologic property of radiation can be used to the patient's advantage in preventing heterotopic ossification. Once stem cells have differentiated and committed to the process of bone formation, radiation is less effective. 29, 52 This is likely because there are more radioresistant, mature bone cells in the cell population at that point than stem cells.
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The genesis for using radiation to prevent heterotopic ossification occurred in 1958, when it was demonstrated in an animal model that a single dose of 30 Gy delivered within 1 week of a bone break impaired healing. 10 As part of that study, it was discovered that the same dose delivered more than 1 week following injury did not have the same effect on repair. This finding demonstrated that the timing of radiation was critical in affecting bone healing and led to other animal studies designed to explore the differences in development and degree of heterotopic ossification based on postoperative timing of the radiation.
Based on these animal studies and experiental awareness of the ability of radiation to stunt the growth of bone in children, physicians at the Mayo Clinic began to use radiation in 1970 in an attempt to prevent development of heterotopic ossification in patients who had undergone surgery for total hip arthroplasty. 53 The use of radiation therapy to prohibit development of initial heterotopic ossification is considered primary prophylaxis. 12 Following publication of the Mayo Clinic's 9-year study in which radiation proved effective in preventing heterotopic ossification, radiation therapy has been used widely and successfully for high-risk patients undergoing total hip arthroplasty since the early 1980s. 53 Numerous studies have since confirmed those initial findings, 44, 49 and preventing heterotopic ossification continues to be one of the most commonly accepted indications for radiation treatment of benign conditions. 54 
Radiation Doses
Because of the potential negative biologic effects of radiation, including cancer and infertility, using radiation therapy as treatment for benign conditions must always consider risk vs benefit. Although the use of radiation for benign conditions was widespread worldwide in the early 20th century, there has been a trend in Western countries allergy should not receive NSAIDs to prevent heterotopic ossification. 48 Even in individuals without initial contraindications, adverse effects occur in as many as 25% to 33% of patients and can be severe enough to warrant discontinuation of NSAIDs. 46 To minimize gastric problems, a mucoprotective drug can be given while the patient is on the NSAID regimen.
28
Alternatively, newer selective COX-2 inhibiting drugs might be as effective as nonselective NSAIDs and have fewer gastrointestinal adverse effects; however, the risk of impaired bone growth in uncemented prostheses might be even greater with COX-2 inhibitors. 50 An additional concern associated with some of the COX-2 inhibiting drugs is the risk of negative cardiovascular effects, most notably the increased risk of myocardial infarction.
28,30
Another disadvantage of NSAIDs is the potential for lack of patient compliance, which can lead to failure to prevent heterotopic ossification. Patients sometimes forget to take the medication or choose not to because of adverse effects. Patient compliance can be monitored by testing for the presence and level of the drug in the bloodstream. One study that measured the amount of indomethacin in the blood found that 40% of patients had no detectable serum level.
22
Despite these concerns, many orthopedists prescribe NSAIDs because of their efficacy, widespread availability, and low cost, which has been estimated to be as little as $20 for a full course of indomethacin tablets. 40 Likewise, some physicians prefer NSAIDs to radiation because of concern over long-term effects of radiation, especially in younger patients. 49 However, other orthopedists opt to use radiation therapy for heterotopic ossification prophylaxis to ensure compliance and avoid the adverse effects associated with the use of NSAIDs. Although studies have shown that indomethacin and radiation therapy can be effective when used alone, some evidence suggests that using a combination of the 2 achieves better outcomes for patients undergoing total hip arthroplasty.
51
Radiation Therapy
It is well known that radiation is more biologically damaging to undifferentiated stem cells than to mature muscle and bone cells. Because heterotopic ossification development depends on converting undifferentiated,
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Adams who received the lower dose. 59 Of interest was that the heterotopic ossification that did develop was primarily Brooker class I or II and therefore was not considered clinically significant. This could be an important consideration, especially in younger patients, and it is likely that future studies will continue to investigate the utility of lower doses in young patients.
Conversely, some patients may benefit from higher doses of radiation than currently are standard. For example, a small study focusing on neurogenic heterotopic ossification found that a single dose of 7 Gy failed to prevent the recurrence of heterotopic ossification in a subset of high-risk patients. 61 Another recent study found that development of heterotopic ossification was more likely in obese individuals than those with average or below-average body mass indices following administration of the standard dose of 7 Gy in a single fraction. Based on that study, it has been suggested that additional research is needed to evaluate the use of higher doses, multiple fractions, or both for individuals with a very high body mass index to customize the treatment strategy to the patient's metabolic and genetic profile.
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Timing of Radiation
The timing of radiation therapy treatment in relation to the surgery is of critical importance, and several investigative trials have explored the optimal time to deliver radiation to achieve the best outcomes.
62,63 A lot of interest exists for the use of preoperative radiation therapy because of its advantages, including pain reduction, elimination of postsurgical movement and the accompanying risk of prosthetic hip dislocations, and less use of staff resources in the radiation oncology department.
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Randomized clinical trials to investigate the efficacy of preoperative radiation therapy were undertaken in the mid-1990s. An early study that included high-risk patients found no difference between 2 groups that received a single fraction of 7 to 8 Gy 4 hours preoperatively or within 48 hours after total hip replacement surgery. 64 This initial success spurred further research, and based on randomized trials involving 410 patients, Seegenschmiedt et al concluded that patients with a preoperative Brooker score of I or II could be treated successfully with either preoperative or postoperative radiation therapy. 62 However, those with a high Brooker score received a more significant benefit from away from radiation therapy for many nonmalignant conditions, such as hemangioma and arthritis, to avoid potentially devastating adverse effects in patients with nonlife-threatening conditions. However, because of its proven effectiveness, prophylactic radiation still is used worldwide for patients at risk of developing heterotopic ossification. 54 Nevertheless, in accordance with the principle of ALARA (as low as reasonably achievable), there is ongoing interest in achieving the lowest radiation dose capable of effectively preventing heterotopic ossification.
Initially, successful radiation treatment was achieved with fractionated regimens delivered postoperatively. Based on clinical experience that showed doses higher than 20 Gy resulted in stunted growth of vertebrae in children, the original radiation regimen used by Coventry and Scanlon for treating heterotopic ossification in humans used a dose of 20 Gy in 10 fractions over 12 days. 53 The doses later were reduced to 10 Gy in 5 fractions without a corresponding decline of efficacy.
55,56 Advantages of decreased dose over a shorter time included a lower risk of carcinogenesis and shorter hospital stays, which resulted in lower cost and reduced inconvenience for the patient.
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Several clinical studies have since compared the fractionated schedules to a single dose of radiation and found them to be equivalent. 57, 58 Based on the radiobiologic principle that a single high dose of radiation is more damaging than the same dose delivered over the course of several fractions, a dose of 10 Gy delivered in 5 fractions is theoretically equivalent to a single dose of 7 Gy. 27 Thus, the recommended radiation dose used for single-fraction treatment has been reduced from 10 Gy to 7 to 8 Gy. 46, 59 Single-fraction radiation now generally is preferred because it is more cost effective and reduces the pain and inconvenience associated with transporting and setting up a treatment field on a patient who has recently had surgery.
Clinical trials continue to evaluate whether dose can be reduced further. A pilot study comparing doses of 5 Gy in 2 fractions to 10 Gy in 5 fractions delivered to high-risk patients who had total hip arthroplasty found no difference in outcomes and suggested that a reduced dose could be used. 60 However, a different study comparing the efficacy of a single fraction of 7 Gy to a single fraction of 5.5 Gy resulted in a significantly higher percentage of heterotopic ossification in the patients CE Directed Reading Heterotopic Ossification fields in these sites resemble those in the hip and are designed to include the entire joint and an adequate margin within parallel-opposed anteroposterior fields (see Figure 7) . A photon energy of 6 MV is adequate to postoperative radiation therapy. Similarly, Kantorowitz and Muff found equivalent results between a single dose of radiation delivered no more than 4 hours preoperatively and the same dose delivered 24 hours or less postoperatively.
65
Although it appears that preoperative radiation is as effective as postoperative radiation, researchers continue to investigate the most appropriate timing of preoperative delivery. For example, Schneider et al reported a significant decrease in heterotopic ossification among rabbits that were irradiated 24 hours preoperatively compared with those irradiated just 4 hours prior to surgery, a finding that was contrary to their hypothesis. 66 In another animal model study with rabbits, researchers reached the same conclusion based on a comparison of 4 different preoperative time points (4 hours, 24 hours, 72 hours, and 3 weeks) for the delivery of 12 Gy in a single fraction. Radiographic evidence 4 months following hip surgery demonstrated that the group of rabbits that received radiation 24 hours prior to surgery had significantly fewer instances of highgrade heterotopic ossification than any of the other 3 groups. 52 It has been postulated that giving radiation a full 24 hours prior to surgery allows expression of radiation-induced mutations in the pluripotential stem cells, thereby prohibiting those cells from differentiating into osteoblasts. Conversely, delivering radiation more than 24 hours prior to surgery might allow sufficient time for repair of damaged osteoblastic cell lines as part of the cell division process.
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Radiation Treatment Sites
Most patients seen in a radiation oncology department for heterotopic ossification are referred by orthopedic surgeons for treatment to the hip. Whether delivered pre-or postoperatively, the radiation treatment technique to the hip consists of parallel-opposed anterior and posterior fields. The photon energy chosen depends on the diameter of the treatment area but most commonly ranges from 6 to 10 MV for the hip. Larger patients might require higher energies to deliver the prescribed dose to the midplane (see Box 1).
12,22
The effectiveness of radiation therapy in the hip has led to its use in other anatomic locations, including the elbow and knee, although use of radiation has not been as widely studied in either of these sites. Treatment 
Radiation Therapy Case Study 1
A 49-year-old man underwent open reduction and internal fixation to repair a fracture dislocation of the left acetabulum sustained in a motor vehicle accident. One day postsurgery, the patient was referred by his orthopedic surgeon for consideration of radiation therapy to prevent heterotopic ossification. The patient consented to treatment and, following simulation, was treated that afternoon with a single fraction of 7 Gy to the left hip using a photon energy of 15 MV. The treatment was delivered via parallel opposed anteroposterior (AP) and posteroanterior (PA) fields using a 3-D conformal, isocentric technique to avoid the bladder and adjacent colon. The patient was treated without incident and was scheduled for follow-up care with his orthopedist (see Figure 6 ). 
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This is likely the result of multiple factors, including the practice of using relatively low doses compared with those commonly used for definitive radiation treatment of cancer.
A second consideration is that the average age and comorbid conditions of patients who typically undergo total hip arthroplasty might result in their death prior to the onset of radiation-induced malignancies, which typically take many years to manifest.
10 However, because trauma can occur at any age, it is possible for middleaged or even younger patients with high risk factors to receive radiation therapy for prevention of heterotopic ossification. For example, the need to prevent heterotopic ossification in joints other than the hip, such as the elbow, is far more common in young patients. In addition, the high incidence of heterotopic ossification in amputated limbs of soldiers, who are often in their 20s or 30s, is a significant problem in the military medical community.
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In 2012, Farris et al reported a case of osteosarcoma occurring at the edge of a radiation field that had received 7 Gy with 6 MV photons in a single fraction to the right hip to prevent heterotopic ossification. 68 The patient, then 26 years of age, received radiation following surgery to repair a hip dislocation and acetabular fracture, as well as multiple other injuries following a motorcycle accident. Years later at age 37, the patient received a diagnosis of stage IIB high-grade sarcoma.
treat the elbow or knee.
12 Sparing a minimum of 2 cm of skin along the field edge prevents lymphedema that would reduce functional outcome. 27 The elbow is the second most commonly treated site after the hip and then the knee. 9 Perhaps because of the frequency of treatment, there is increased interest in demonstrating the efficacy of prophylactic radiation in the elbow and several studies have been published. 13, 26, 33 The shoulder also has been irradiated because it is at particular risk of heterotopic ossification in individuals with a spinal cord injury. 55 In rare cases, the temporomandibular joint has been treated.
9
Although the radiation beam arrangement is relatively simple for heterotopic ossification prophylaxis, and treatment fields originally were designed on a conventional simulator or even a treatment unit, it might be advantageous to use CT-based treatment planning when available, based on results of a study by Mourad et al. 33 Their retrospective, single-institution study found that patients who had been clinically simulated on a linear accelerator just prior to treatment developed heterotopic ossification at a rate of up to 4.7 times higher than patients whose treatment was planned using CT-based simulation. Forty percent of the patients received indomethacin in combination with radiation therapy and those patients were found in both the clinical and CT simulation group. Because the study delivered the same dose (7 Gy) in the same time frame (within 72 hours postoperatively) to all patients and the effect of indomethacin use was adjusted for, the authors suggested that results were better in the CT-simulated group because of improved visualization of internal soft tissue around the surgical bed. However, the use of CT simulation increases the cost and radiation exposure in patients being treated for a benign condition.
Radiation's Adverse Effects
Despite concerns about triggering cancer within an irradiated area, until recently no cases of radiation-induced malignancies were documented in patients treated with prophylactic radiation therapy for heterotopic ossification. 
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Heterotopic Ossification dose of scatter radiation received by the gonads. Thermoluminescent dosimeters in tissue phantoms have been used to assess dose to the testes as well as to the ovaries. Oertel et al 70 reported the testicular dose measured in this manner to be 21 cGy (0.21 Gy), but other reports estimated the dose might be as high as 28 cGy (0.28 Gy).
10 This dose is not high enough to cause permanent azoospermia (no living sperm), but temporary oligospermia (low sperm count) is plausible.
1
For this reason, the use of a testicular shield should be standard practice when irradiating the hip, especially in younger men. Although ovarian dose is higher, the doses used to treat heterotopic ossification are not high enough to cause infertility in women. Kokona et al measured dose scattered to the testicles as a result of irradiation of the elbow for prevention of heterotopic ossification and found it to be negligible.
1 Similar results have been reported at other sites associated with treatment of the shoulder, knee, and ankle; thus, testicular shielding has not been deemed necessary when irradiating areas other than the hip.
Although fertility effects appear to be minimal, there is no threshold for induction of hereditary mutation. It has been reported that radiation therapy to the hip at doses used to treat heterotopic ossification increases the risk of adverse genetic effects compared with the expected rate of spontaneous mutations, although the risk abates over time. This risk has been assessed to be approximately 7 times greater than the risk associated with an abdominal CT scan.
1 Because of this, men should be advised against fathering children for 9 weeks after radiation treatment to avoid fertilization by mutated sperm. The same problem is not seen in women because damaged eggs generally do not ovulate.
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Because of the nature of the conditions for which heterotopic ossification risk is increased, patients who receive perioperative radiation therapy for prophylaxis usually have prosthetic devices. The use of cementless prosthetic components in joint replacement surgery assumes the ability of remaining bone to attach and grow into the device in a manner that will provide adequate stability. Failure of the bone to do so is referred to as nonunion. Nonunion is a poor outcome because the patient might experience joint dislocations that can be associated with fracture, which increases the risk of heterotopic This case is remarkable in that the dose was much lower than what generally has been considered the threshold dose for development of a radiation-induced sarcoma.
Although the induction of solid tumors such as sarcoma is particularly worrisome, only 2 cases of sarcoma have been reported to have occurred with doses less than 30 Gy, making it an extremely rare occurrence.
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However, this does not eliminate all concerns because young people tend to be mobile and are sometimes lost to long-term follow up. The risk of solid tumor induction rises with age, with an additional risk of 0.3% at age 50 years, up to 1% at age 65 years. 70 Because it can take more than a decade before the appearance of sarcoma, the younger the patient, the greater the risk.
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In addition to solid tumors, there is a risk of leukemia induction. This increased risk peaks 5 years after radiation and then declines, but continues to be higher than for nonirradiated individuals for up to 30 years. The cumulative risk of leukemia at age 65 for patients who received radiation is reported to be 0.8%, almost double that of nonirradiated individuals (0.43%). 70 To put this in perspective, radiation treatment for heterotopic ossification prophylaxis is thought to carry risk of cancer induction similar to that of certain diagnostic imaging studies. For example, Oertel et al stated that potential harm from administration of a dose of 8 Gy to the hip carries approximately 5 times the risk of a single abdominal CT scan.
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Although the lifetime risk of radiation-induced malignancies is low, given any possibility at all of future malignancy, it is important for patients and physicians to understand the potential long-term risks of cancer induction when prophylactic radiation therapy is used to treat benign conditions. Acknowledging this risk of cancer induction, at least one facility in the United Kingdom established a formal institutional protocol of offering radiation therapy only to patients with at least a 50% chance of developing heterotopic ossification after surgery.
71
In addition to cancer induction, there is concern regarding potential effects of radiation on the gonads, including reduced fertility for both men and women and the possibility of genetic mutations in future offspring.
1 Given that the most common application of preventive radiation therapy for heterotopic ossification is to the hip, consideration should be given to the CE Directed Reading Adams nonunion have not been eliminated. For example, despite reported success with radiation prophylaxis to the elbow, a recent prospective clinical trial to assess the effectiveness of radiation therapy to prevent heterotopic ossification in high-risk patients with elbow injuries was stopped prematurely because of a significant number of adverse events related to nonunion.
33 Similar problems with malunion ossification. 43 For this reason, surgical revision often is required, and with additional surgery comes a corresponding increase in risk, inconvenience, and cost. It is therefore understandable that some surgeons and radiation oncologists worry that radiation might increase the rate of prosthetic failure due to nonunion.
Such concern has arisen because radiation is known to decrease bone growth and delay wound healing. Early justification of these fears was based on an animal study that found loosening of prosthetic devices in rabbit tibiae that were irradiated with 1000 cGy (10 Gy) in 5 fractions.
57 Stability of the prosthesis was measured by the amount of force necessary to pull the bone from implanted rods in both irradiated and nonirradiated legs. While the irradiated field was initially unstable as measured at 2 weeks, it was noted that by 3 weeks postsurgery no difference was found between the irradiated and nonirradiated tibiae.
Nevertheless, additional concerns have been based on reports of trochanteric nonunion incidence rates of 12% to 30% in patients who received radiation therapy to the hip following an osteotomy of the trochanter secondary to removal of a prosthesis during revision surgery. These rates of bone nonunion were significantly higher than the 2% to 15% incidence that would be expected following the same surgical procedure without accompanying radiation therapy. 7 It should be noted that these nonunion complications occurred within treatment portals that did not shield the osteotomy site from radiation. Surgical techniques have since evolved that reduce the chance of trochanteric nonunion, making this a largely moot point for current patients. However, perhaps because of this experience, some radiation oncologists choose to shield the acetabulum when irradiating hips with noncemented prosthetic devices despite the lack of clinical evidence that this is necessary (see Box 2). 10 Conversely, several studies have found no increased risk of prosthetic failure associated with radiation of the hip. One study found that when shielding of the acetabulum was done, there was a higher incidence of radiation failure to prevent heterotopic ossification. Based on those results, Balboni et al suggested that the practice of shielding the prosthesis should be avoided. 43 However, the anxiety and confusion regarding the risks of 
Radiation Therapy Case Study 2
A 61-year-old man with a several-year history of increasing pain in the right hip was scheduled to undergo a total hip arthroplasty and reconstruction of the acetabulum for extensive arthritic changes of the hip. He also had significant flowing osteophytes in the lower lumbar spine, consistent with diffuse idiopathic skeletal hyperostosis syndrome. Based on his increased risk for heterotopic ossification following his surgery, the patient was referred to radiation oncology for consideration of prophylactic radiation therapy to the hip. The patient was consulted in the department several days prior to surgery. During the consultation, risks and benefits were explained and consent for treatment was given.
One day after surgery, the patient arrived at the cancer center and was placed on the conventional simulator, where AP and lateral simulation images were obtained. The field outline was then drawn on the image by the radiation oncologist and digitized into the computer by the radiation therapist to enable multileaf collimators on the linear accelerator to shape the treatment area. As seen in Figure 8 , multileaf collimators were used to shield the prosthesis at the acetabulum. The patient separation was obtained with calipers, the source-toskin distances were determined, and triangulation alignment points were marked. The physicist performed hand calculations to ascertain the monitor units based on the dose prescription and information obtained during the simulation process. A single dose of 7.5 Gy was delivered in one fraction to the midplane of the patient via an AP/PA isocentric technique with a 10 MV photon beam within 24 hours of the surgery. Prior to treatment, the AP and PA portals were imaged to verify field shape and placement. Although the patient arrived at the department as an outpatient, because of his recent postoperative status and the potential discomfort involved, every effort was made to minimize wait time. The entire process-from simulation to completion of treatment-took place within 75 minutes.
in elbows treated with radiation for secondary prophylaxis were not found in other retrospective studies, leading to speculation that postoperative complications are less common following a surgical revision than for repair of initial trauma.
12
Conclusion
As the general population ages, heterotopic ossification will continue to be a significant issue for orthopedic physicians. Although indomethacin is widely used for prophylaxis, radiation therapy has proven to be equally effective for this purpose and is a viable treatment option for this benign condition, either alone or in combination with indomethacin. Most prophylactic radiation therapy for heterotopic ossification is given to the hip, and the current standard is to deliver a dose of 7 to 8 Gy in a single fraction within 24 hours preoperatively or 72 hours postoperatively. Further study might establish dose and delivery schedule protocols for anatomic sites other than the hip, as well as protocols that are customized for individual patient differences. 
